Affording Immunotherapy in Canada | Cost & Support Strategies

Affording Immunotherapy in Canada

Comprehensive Cost & Support Strategies (2026 Edition)

Understanding Immunotherapy Costs in Canada

1. The “Where” Matters: Hospital vs. Home

  • In-Hospital (IV Infusion): If your immunotherapy is administered via IV at a hospital or cancer centre, the drug is typically 100% covered by the provincial government through the “Cancer Care” budget. You should not receive a bill for the drug or the administration.

  • Take-Home (Oral/Pills): If your treatment is a pill taken at home, it is treated like a standard prescription. This means you must rely on Private Insurance, Provincial Drug Plans (like Ontario’s Trillium or BC PharmaCare), or Manufacturer Support.

2. Provincial “Safety Nets” (2026 Updates)

Each province has a “catastrophic” drug program designed to limit your out-of-pocket costs based on your income:

  • Ontario (Trillium Drug Program): If your drug costs are high compared to your income (usually over 4%), Trillium will cover the remainder after you pay a quarterly deductible.

  • British Columbia (National Pharmacare Expansion): As of March 2026, BC has expanded its plan. While focused on diabetes and hormone therapy, the integration has streamlined “Special Authority” approvals for many cancer drugs.

  • Quebec (RAMQ): Quebec requires all residents to have drug insurance. If you don’t have a private plan, the public RAMQ plan has a maximum monthly “out-of-pocket” cap (approx. $96 – $100).

3. Patient Support Programs (PSPs)

In Canada, pharmaceutical companies are prohibited from advertising directly to patients, but they provide robust financial assistance through PSPs. These programs are often the “secret weapon” for affording care:

  • Co-pay Assistance: They can pay the 20% “gap” that your private insurance doesn’t cover.

  • Bridging: They provide free medication while you wait for insurance paperwork to be approved.

  • Compassionate Use: For patients with no insurance and no provincial coverage, they may provide the drug for free or at a massive discount.

Common PSP Names:

  • Merck Access Program (MAP): For Keytruda®

  • BMS 360™: For Opdivo® and Yervoy®

  • AstraZeneca Program: For Imfinzi®